Home › NDC Lookup › Ingredients › Redicare Antacid Mint Flavored › 71105-0036-02
⚪image loading
(from DailyMed)

Redicare Antacid Mint Flavored 420 mg Tablet, Chewable — NDC 71105-036-02 (Billing 71105-0036-02)

by Redicare LLC · 50 PACKET in 1 BOX / 2 TABLET, CHEWABLE in 1 PACKET

This is a package of Redicare Antacid Mint Flavored 420 mg Tablet, Chewable from Redicare LLC, marketed since Feb 2025 and currently FDA-listed. It is this product's only package size.

NDC 71105-0036-02
🏷️ FDA NDC (as labeled) 71105-036-02 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 71105-036-02 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
71105 labeler · 036 product · 02 package
Package marketed since
Feb 27, 2025
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 7110503602 8
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 71105-036-02
Product NDC 71105-036
11-digit billing NDC 71105003602
RxCUI 313884
UNII H0G9379FGK
Application # M001
SPL Set ID 2f259f79-d321-5566-e063-6294a90a1522
Established class (EPC) Blood Coagulation Factor; Cations; Phosphate Binder
Mechanism of action Phosphate Chelating Activity
Physiologic effect Increased Coagulation Factor Activity
Chemical class Calcium; Divalent
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-02-27
Route ORAL
Dosage form TABLET, CHEWABLE
Substance CALCIUM CARBONATE
Quick answers
  • RxCUI (RxNorm): 313884
Why two NDCs? The FDA registers this code as 71105-036-02 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 71105-0036-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Calcium compounds class.

Drug family (ATC) Calcium compounds, Calcium
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📖 What it is MedlinePlus · NLM

Calcium carbonate is a dietary supplement used when the amount of calcium taken in the diet is not enough. Calcium is needed by the body for healthy bones, muscles, nervous system, and heart. Calcium carbonate also is used as an antacid to relieve heartburn, acid indigestion, and upset stomach. It is available with or without a prescription. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Most often it's an antacid. It relieves heartburn, acid indigestion, sour stomach and upset stomach tied to those symptoms. A few supplement products have other uses, like bone sup...
  • What is calcium carbonate usually used for?
  • You chew it when symptoms come on. Many labels say to chew or crush the tablets completely and not swallow them whole. The number of tablets varies by product, so read your label o...
  • Many labels say not to use the maximum dose for more than 2 weeks unless a doctor is supervising you. If your symptoms last longer than 2 weeks, check in with your doctor.
📖 Read our full Calcium Carbonate guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
71105-0036-02 You're viewing this Main listing 50 PACKET in 1 BOX / 2 TABLET, CHEWABLE in 1 PACKET 2025-02-27 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
PhysiciansCare Antacid 420 mg 00924-0086-00 Acme 2 tablets — — FDA listed —
First Aid Only Antacid 420 mg 00924-0287-01 Acme 2 tablets — — FDA listed —
Belmora MELOX AGRURA 420 mg 27854-0120-01 Belmora, 2 tablets — — FDA listed —
Medique Alcalak 420 mg 47682-0201-13 Unifirst 2 tablets — — FDA listed —
Medi-First Antacid 420 mg 47682-0820-13 Unifirst 2 tablets — — FDA listed —
Medi-First Plus Antacid 420 mg 47682-0920-33 Unifirst 2 tablets — — FDA listed —
Unishield Antacid 420 mg 49314-1013-03 Unishield 2 tablets — — FDA listed —
Nutralox 420 mg 50090-2440-00 A-S 2 tablets — — FDA listed —
Nutralox 420 mg 50332-0151-01 HART 2 tablets — — FDA listed —
Antacid 420 mg 58228-0091-01 ProStat 20000 tablets — — FDA listed —
McKesson Antacid Calcium Carbonate 420 mg 68599-1411-03 McKesson 2 tablets — — FDA listed —
Calcium Carbonate 420 mg 69168-0036-54 Allegiant 22058 tablets — — FDA listed —
Antacid 420 mg 69396-0142-01 Trifecta 100 tablets — — FDA listed —
Uline Antacid 420 mg 69790-0820-33 Uline 2 tablets — — FDA listed —
Redicare Antacid Mint Flavored 420 mgthis 71105-0036-02 Redicare 2 tablets — — FDA listed —
Thompson Antacid 420 mg 73408-0921-33 Thompson 2 tablets — — FDA listed —
Mint Antacid 100 420 mg 73598-1142-01 JHK 2 tablets — — FDA listed —
Mint Antacid 250 420 mg 73598-1144-01 JHK 2 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Feb 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerRedicare LLC
FDA applicationM001 (OTC MONOGRAPH DRUG)
Labeler code71105
First marketedFeb 2025
Product typeHuman Otc Drug
Portfolio12 products on file

More NDCs from Redicare LLC labeler code 71105

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Ask a Doctor or Pharmacist Before Use If 📄 When Using This Product 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 17 words ▾

Uses: relieves ■ heartburn ■ sour stomach ■ acid indigestion ■ upset stomach due to these symptoms

⏱️ Dosage and Administration 16 words ▾

Directions: ■ chew 2 tablets every 2-3 hours or as symptoms occur, repeat hourly if needed

⚠️ Warnings 87 words ▾

Warnings: Ask a doctor or pharmacist before use if you ■ have kidney disease ■ are taking a prescription drug Antacids may interact with certain prescription drugs When using this product do not take more than 19 tablets in a 24 hour period or use the maximum dosage of this product for more than two weeks except under the advice and supervision of a doctor. If symptoms persist for more than two weeks, stop using this product and see a doctor. Keep out of reach of children.

📦 Storage and Handling 35 words ▾

Other Information: ■ Calcium content per tablet: 168mg ■ store at 15°- 30°C (59°-86°F) ■ do not use if imprinted safety seal under cap is broken or missing ■ Phenylketonurics: each tablet contains 1.5mg phenylalanine

🧪 Active Ingredient 8 words ▾

Active Ingredient (in each tablet) Calcium carbonate 420mg

🧪 Inactive Ingredients 11 words ▾

Inactive ingredients: aspartame, croscarmellose sodium, magnesium stearate, maltodextrin, mint flavor, sorbitol

🎯 Purpose 2 words ▾

Purpose Antacid

📄 Ask a Doctor or Pharmacist Before Use If 26 words ▾

Ask a doctor or pharmacist before use if you ■ have kidney disease ■ are taking a prescription drug Antacids may interact with certain prescription drugs

📄 When Using This Product 54 words ▾

When using this product do not take more than 19 tablets in a 24 hour period or use the maximum dosage of this product for more than two weeks except under the advice and supervision of a doctor. If symptoms persist for more than two weeks, stop using this product and see a doctor.

📄 Keep Out of Reach of Children 6 words ▾

Keep out of reach of children.

📄 Package Label / Principal Display Panel 3 words ▾

Principal Display

Packet

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Redicare LLC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Redicare LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 71105-0011-02 · Redicare 71105-0105-05 · Redicare →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.